CompletedNot applicableNCT03126266

Re-Irradiation of Progressive or Recurrent DIPG

Studying Diffuse intrinsic pontine glioma

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Calgary
Principal Investigator: Lucie Lafay-Cousin, MD
University of Calgary
Intervention: re-irradiation(radiation)
Enrollment: 27 enrolled
Eligibility: All sexes
Timeline: 2017 – 2024

Study locations (18)

The Children's Hospital at Westmead, Westmead, New South Wales, Australia
Queensland Children's Hospital, Brisbane, Queensland, Australia
Monash Children's Hospital, Clayton, Victoria, Australia
Royal Children's Hospital, Parkville, Victoria, Australia
Perth Children's Hospital, Perth, Western Australia, Australia
Alberta Children's Hospital, Calgary, Alberta, Canada
Stollery Children's Hospital, Edmonton, Alberta, Canada
BC Children's Hospital, Vancouver, British Columbia, Canada
Janeway Child Health Centre, St. John's, Newfoundland and Labrador, Canada
IWK Health Centre, Halifax, Nova Scotia, Canada
McMaster Children's Hospital, Hamilton, Ontario, Canada
Children's Hospital at London Health Sciences Centre, London, Ontario, Canada
Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada
The Hospital for Sick Children, Toronto, Ontario, Canada
CHU de Québec-Université Laval, Laval, Quebec, Canada
+3 more locations on ClinicalTrials.gov

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03126266 on ClinicalTrials.gov

Other trials for Diffuse intrinsic pontine glioma

Additional recruiting or active studies for the same condition.

See all trials for Diffuse intrinsic pontine glioma →

← Back to all trials